Development and validation of risk prediction models for new-onset type 2 diabetes in adults with impaired fasting glucose

被引:0
|
作者
Zheng, Manqi [1 ]
Wu, Shouling [2 ]
Chen, Shuohua [2 ]
Zhang, Xiaoyu [1 ,3 ]
Zuo, Yingting [1 ]
Tong, Chao [1 ]
Li, Haibin [4 ,5 ]
Li, Changwei [6 ]
Yang, Xinghua [1 ]
Wu, Lijuan [1 ]
Wang, Anxin [7 ,8 ]
Zheng, Deqiang [1 ,9 ]
机构
[1] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Kailuan Gen Hosp, Dept Cardiol, Tangshan, Hebei, Peoples R China
[3] Capital Med Univ, Sanbo Brain Hosp, Dept Anesthesiol, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Chaoyang Hosp, Heart Ctr, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Chaoyang Hosp, Beijing Key Lab Hypertens, Beijing, Peoples R China
[6] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA
[7] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[8] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[9] Lund Univ, Ctr Primary Hlth Care Res, Dept Clin Sci Malmo, Lund, Sweden
基金
北京市自然科学基金;
关键词
Impaired fasting glucose; LASSO; Risk prediction model; Type; 2; diabetes; Web calculator; FATTY LIVER; MELLITUS; SCORE; POPULATION; DIAGNOSIS; TOLERANCE; ACCURACY; DISEASE;
D O I
10.1016/j.diabres.2023.110571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To develop and validate sex-specific risk prediction models based on easily obtainable clinical data for predicting 5-year risk of type 2 diabetes (T2D) among individuals with impaired fasting glucose (IFG), and generate practical tools for public use.Methods: The data used for model training and internal validation came from a large prospective cohort (N = 18,384). Two independent cohorts were used for external validation. A two-step approach was applied to screen variables. Coefficient-based models were constructed by multivariate Cox regression analyses, and score-based models were subsequently generated. The predictive power was evaluated by the area under the curve (AUC).Results: During a median follow-up of 7.55 years, 5697 new-onset T2D cases were identified. Predictor variables included age, body mass index, waist circumference, diastolic blood pressure, triglycerides, fasting plasma glucose, and fatty liver. The proposed models outperformed five existing models. In internal validation, the AUCs of the coefficient-based models were 0.741 (95% CI 0.723-0.760) for men and 0.762 (95% CI 0.720-0.802) for women. External validation yielded comparable prediction performance. We finally constructed a risk scoring system and a web calculator.Conclusions: The risk prediction models and derived tools had well-validated performance to predict the 5-year risk of T2D in IFG adults.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Association of visceral adiposity index with new-onset type 2 diabetes and impaired fasting glucose in hypertensive Chinese adults
    Chun Zhou
    Zhuxian Zhang
    Mengyi Liu
    Yuanyuan Zhang
    Panpan He
    Qinqin Li
    Di Xie
    Min Liang
    Guobao Wang
    Jing Nie
    Chengzhang Liu
    Yun Song
    Lishun Liu
    Binyan Wang
    Xiaobin Wang
    Xiping Xu
    Xianhui Qin
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2022, 27 : 505 - 514
  • [2] Association of visceral adiposity index with new-onset type 2 diabetes and impaired fasting glucose in hypertensive Chinese adults
    Zhou, Chun
    Zhang, Zhuxian
    Liu, Mengyi
    Zhang, Yuanyuan
    He, Panpan
    Li, Qinqin
    Xie, Di
    Liang, Min
    Wang, Guobao
    Nie, Jing
    Liu, Chengzhang
    Song, Yun
    Liu, Lishun
    Wang, Binyan
    Wang, Xiaobin
    Xu, Xiping
    Qin, Xianhui
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2022, 27 (02) : 505 - 514
  • [3] The development and validation of the Portuguese risk score for detecting type 2 diabetes and impaired fasting glucose
    Gray, Laura J.
    Barros, Henrique
    Raposo, Luis
    Khunti, Kamlesh
    Davies, Melanie J.
    Santos, Ana Cristina
    PRIMARY CARE DIABETES, 2013, 7 (01) : 11 - 18
  • [4] Evaluatioin of the safety, efficacy and tolerability of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
    Marbury, T
    Schwartz, S
    Rosenberg, M
    Johnston, P
    Jariwala, N
    Shukla, U
    Becker, R
    Saoud, J
    DIABETES, 2003, 52 : A451 - A452
  • [5] A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
    Marbury, T. C.
    Schwartz, S.
    Rosenberg, M. A.
    Jarlwala, N.
    Becker, R. H. A.
    Johnston, P. S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (05) : 282 - 288
  • [6] Comment on: New-Onset Diabetes and Impaired Fasting Glucose After a Liver Transplant: Risk Analysis and the Effect of Tacrolimus Dosage
    Kabir, Ali
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 (01) : 85 - 85
  • [7] Predicting Risk for New-Onset Type 2 Diabetes in Chinese People with Coronary Heart Disease and Impaired Glucose Tolerance
    Xu, Shishi
    Scott, Charles A.
    Coleman, Ruth L.
    Tuomilehto, Jaakko
    Holman, Rury R.
    DIABETES, 2019, 68
  • [8] Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
    Xu, S.
    Scott, C.
    Coleman, R. L.
    Tuomilehto, J.
    Holman, R. R.
    DIABETOLOGIA, 2019, 62 : S150 - S150
  • [9] Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model
    Clift, Ash Kieran
    Tan, Pui San
    Patone, Martina
    Liao, Weiqi
    Coupland, Carol
    Bashford-Rogers, Rachael
    Sivakumar, Shivan
    Hippisley-Cox, Julia
    BRITISH JOURNAL OF CANCER, 2024, 130 (12) : 1969 - 1978
  • [10] Predictive value for cumulative heart rate exposure in new-onset impaired fasting glucose and diabetes mellitus
    Sun, Lixia
    Li, Chunhui
    Liu, Jiqiang
    Li, Haiyan
    Zhao, Hualing
    Song, Lu
    Wang, Yiming
    Chen, Shuohua
    Liu, Jie
    Zhang, Ruiying
    Zhao, Quanhui
    Cong, Hongliang
    Wu, Shouling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 3069 - 3078